PharmaSGP Holding SE

BATS-CHIXE:PSGD Stock Report

Market Cap: €280.6m

PharmaSGP Holding Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Natalie Weigand

Chief executive officer

€865.0k

Total compensation

CEO salary percentage34.7%
CEO tenure4.3yrs
CEO ownershipn/a
Management average tenureno data
Board average tenure4.3yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Natalie Weigand's remuneration changed compared to PharmaSGP Holding's earnings?
DateTotal CompensationSalaryCompany Earnings
Mar 31 2024n/an/a

€18m

Dec 31 2023€865k€300k

€16m

Sep 30 2023n/an/a

€15m

Jun 30 2023n/an/a

€14m

Mar 31 2023n/an/a

€13m

Dec 31 2022€314k€250k

€12m

Sep 30 2022n/an/a

€11m

Jun 30 2022n/an/a

€11m

Mar 31 2022n/an/a

€11m

Dec 31 2021€272k€250k

€11m

Sep 30 2021n/an/a

€8m

Jun 30 2021n/an/a

€8m

Mar 31 2021n/an/a

€9m

Dec 31 2020€279k€258k

€11m

Sep 30 2020n/an/a

€16m

Jun 30 2020n/an/a

€17m

Mar 31 2020n/an/a

€17m

Dec 31 2019€141k€141k

€17m

Compensation vs Market: Natalie's total compensation ($USD924.94K) is about average for companies of similar size in the UK market ($USD979.53K).

Compensation vs Earnings: Natalie's compensation has increased by more than 20% in the past year.

CEO

Natalie Weigand (43 yo)

4.3yrs

Tenure

€865,000

Compensation

Ms. Natalie Weigand serves as the Chief Executive Officer at PharmaSGP Holding SE since June 2020 and also serves as a Member of Management Board since March 04, 2020. She joined the FUTRUE Group as the le...

Board Members

NamePositionTenureCompensationOwnership
Axel Rebien
Member of the Supervisory Board4yrs€50.00kno data
Madlena Hohlefelder
Deputy Chairwoman of the Supervisory Board4.3yrsno data48.95%
€ 137.3m
Clemens Fischer
Chairman of the Supervisory Board4.3yrsno datano data

4.3yrs

Average Tenure

49yo

Average Age

Experienced Board: PSGD's board of directors are considered experienced (4.3 years average tenure).